The 19-year-old phenom, who is set to finally take over as a starter in the 2025 season, said he has been bullied by his famous uncles, Peyton and Eli, and they have even given him wedgies.

Every year, a new list of players is inducted, and this time, there are 15 finalists left, including former New York Giants quarterback Eli Manning, who is attempting to make it in his first year ...

In the case of Eli Manning, you cannot. And while Peyton’s overall career might be better, Eli got a leg up on older brother when he won his second Super Bowl MVP following the 2011 season ...

Ernie Accorsi has few regrets when it comes to Eli Manning and his time with the New York Giants. Perhaps the biggest one for the former general manager who famously pulled off the 2004 NFL Draft ...

Prices for the online bottles start at $99 for a 750 mL bottle. Knob Creek, Eli Manning introduce Bold Picks bourbon Knob Creek is partnering with football legend and New Orleans native ...

Long before Eli Manning became a New York Giants legend who won two Super Bowl Most Valuable Player Awards with that franchise, he was a top-tier prospect ahead of the 2004 NFL Draft for his play ...

The official ending of Eli Manning's storied 16-year NFL career with the New York Giants was in many ways the most fitting. As Manning said good-bye to his life as an active player, the two-time ...

CNBC's Jim Cramer on Friday walked investors through an earnings-heavy week, highlighting reports from Amazon, Alphabet, Eli Lilly and Palantir, as well as a key inflation metric from the Labor ...

“The Art of Winning: Lessons from a Life in Football' will hit shelves this spring Carly Tagen-Dye is the Books editorial assistant at PEOPLE, where she writes for both print and digital ...

Editor's note: This story originally published Nov. 27, 2024. It has been updated to reflect the current status of Eli Manning's Hall of Fame candidacy. EAST RUTHERFORD, N.J. -- Eli Manning has ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...